bioMérieux
Delphine Boissin is a seasoned finance professional with extensive experience in transformation management at bioMérieux since June 2017, currently serving as Senior Director of Finance Transformation. Boissin oversees teams managing large-scale transformation initiatives including end-to-end process improvements and new business model implementations, alongside strategizing for shared services. Prior roles at bioMérieux encompassed Master Data Program Manager and Senior Project Manager, focusing on optimizing support functions and finance processes. Earlier career experience includes a tenure at Accenture as an Experienced Manager in Finance Strategy, specializing in finance transformation for major corporations. Educational credentials include an MBA in Finance & Accounting from Indiana University of Pennsylvania and a degree in Business with a focus on Finance from Institut Commercial de Nancy.
This person is not in any teams
This person is not in any offices
bioMérieux
20 followers
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.